Amgen Inc. (AMGN) Financials

AMGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 92.5 billion 83.3 billion
Dec. 31, 2025 90.6 billion 81.9 billion
Sept. 30, 2025 90.1 billion 80.5 billion
June 30, 2025 87.9 billion 80.5 billion

AMGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 1.5 billion 75.0 million
Dec. 31, 2025 961.0 million 125.0 million
Sept. 30, 2025 4.2 billion 127.0 million
June 30, 2025 1.9 billion 157.0 million

AMGN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 1.8 billion
Dec. 31, 2025 1.3 billion
Sept. 30, 2025 3.2 billion
June 30, 2025 1.4 billion

AMGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 12.0 billion 51.9 billion -
Dec. 31, 2025 9.1 billion 50.0 billion -
Sept. 30, 2025 9.4 billion 52.4 billion -
June 30, 2025 8.0 billion 53.8 billion -

AMGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 544.0 million
Dec. 31, 2025 543.0 million
Sept. 30, 2025 542.0 million
June 30, 2025 541.0 million

AMGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 712.0 million 1.7 billion 1.6 billion -
Dec. 31, 2025 642.0 million 2.2 billion 1.9 billion -
Sept. 30, 2025 436.0 million 1.9 billion 1.7 billion -
June 30, 2025 369.0 million 1.7 billion 1.7 billion -

AMGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 8.6 billion 2.7 billion
Dec. 31, 2025 9.9 billion 1.8 billion
Sept. 30, 2025 9.6 billion 3.1 billion
June 30, 2025 9.2 billion 3.0 billion

AMGN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AMGN

List: Contenders

Price: $355.20

52 week price:
267.83
391.29

Dividend Yield: 2.88%

5-year range yield:
2.68%
3.69%

Forward Dividend Yield: 2.84%

Payout Ratio: 155.17%

Payout Ratio Range:
-1069.03%
217.24%

Dividend Per Share: 10.08 USD

Earnings Per Share: 14.37 USD

P/E Ratio: 23.04

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 1.7 million

Ebitda: 3.6 billion

Market Capitalization: 188.7 billion

Average Dividend Frequency: 4

Years Paying Dividends: 16

DGR3: 7.77%

DGR5: 8.72%

DGR10: 12.87%

Links: